Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxysteroid 17-beta dehydrogenase 7 pseudogene 1 (HSD17B7P1) is a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but generally non-functional; it is not known to produce a functional protein or play an active role in biological processes, disease pathways, or drug response. HSD17B7P1 is annotated as a pseudogene, not a protein coding gene. It is not considered a therapeutic or drug target (such as an enzyme, receptor, transporter, or similar), and there is no evidence of biological activity, disease involvement, or drug interaction associated with HSD17B7P1. The active, protein-coding homolog is HSD17B7 (Hydroxysteroid 17-beta dehydrogenase 7), which is an enzyme involved in steroid and cholesterol biosynthesis and is implicated in several disease processes; however, HSD17B7P1 is distinct and non-functional by current annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxysteroid 17-beta dehydrogenase 7 pseudogene 1 (HSD17B7P1).